Company Profile
Aptose Biosciences, Inc. Stock Price, News & Analysis
- Ticker:
- APTO
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Aptose Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Why the stock is moving
APTO is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Aptose Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Aptose Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Aptose Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Aptose Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
Aptose Reports First Quarter 2026 Results
Source: Aptose Biosciences, Inc.
- 03
- 04
Aptose Reports Third Quarter 2025 Results
Source: Aptose Biosciences, Inc.
- 05
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
Source: Aptose Biosciences, Inc.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Aptose Biosciences, Inc. do?
Aptose Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is APTO stock listed?
Aptose Biosciences, Inc. (APTO) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Aptose Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Aptose?
Aptose Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Aptose Biosciences, Inc. targeting with Aptose?
Aptose Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Aptose Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.